These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19897869)

  • 1. Variations in serum concentration of phenobarbitone in dogs receiving regular twice daily doses in relation to the times of administration.
    Monteiro R; Anderson TJ; Innocent G; Evans NP; Penderis J
    Vet Rec; 2009 Nov; 165(19):556-8. PubMed ID: 19897869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of timing of blood collection on serum phenobarbital concentrations in dogs with epilepsy.
    Levitski RE; Trepanier LA
    J Am Vet Med Assoc; 2000 Jul; 217(2):200-4. PubMed ID: 10909458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenobarbitone concentrations in the hair, saliva and plasma of eight epileptic dogs.
    Dunnett M; Littleford A; Lees P
    Vet Rec; 2002 Jun; 150(23):718-24. PubMed ID: 12081307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver-related biochemical changes in the serum of dogs being treated with phenobarbitone.
    Aitken MM; Hall E; Scott L; Davot JL; Allen WM
    Vet Rec; 2003 Jul; 153(1):13-6. PubMed ID: 12877211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing serum concentrations of levetiracetam in dogs with epilepsy.
    Saint-Maxent M; Juette T; Parent J; Castel A; Parmentier T
    J Vet Intern Med; 2024; 38(4):2249-2256. PubMed ID: 38888491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low concentrations of cerebrospinal fluid GABA correlate to a reduced response to phenobarbital therapy in primary canine epilepsy.
    Podell M; Hadjiconstantinou M
    J Vet Intern Med; 1999; 13(2):89-94. PubMed ID: 10225597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of chronic administration of phenobarbital, or bromide, on pharmacokinetics of levetiracetam in dogs with epilepsy.
    Muñana KR; Nettifee-Osborne JA; Papich MG
    J Vet Intern Med; 2015; 29(2):614-9. PubMed ID: 25711374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of extended-release levetiracetam in epileptic dogs when administered alone, with phenobarbital or zonisamide.
    Muñana KR; Otamendi AJ; Nettifee JA; Papich MG
    J Vet Intern Med; 2018 Sep; 32(5):1677-1683. PubMed ID: 30238679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenobarbitone-induced haematological abnormalities in idiopathic epileptic dogs: prevalence, risk factors, clinical presentation and outcome.
    Bersan E; Volk HA; Ros C; De Risio L
    Vet Rec; 2014 Sep; 175(10):247. PubMed ID: 24836432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug choice and therapeutic drug monitoring in the management of canine primary epilepsy.
    Vaughan-Scott T; Taylor JH
    J S Afr Vet Assoc; 1999 Dec; 70(4):172-6. PubMed ID: 10855844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic serum drug concentrations in epileptic dogs treated with potassium bromide alone or in combination with other anticonvulsants: 122 cases (1992-1996).
    Trepanier LA; Van Schoick A; Schwark WS; Carrillo J
    J Am Vet Med Assoc; 1998 Nov; 213(10):1449-53. PubMed ID: 9828942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum total thyroxine, total triiodothyronine, free thyroxine, and thyrotropin concentrations in epileptic dogs treated with anticonvulsants.
    Kantrowitz LB; Peterson ME; Trepanier LA; Melián C; Nichols R
    J Am Vet Med Assoc; 1999 Jun; 214(12):1804-8. PubMed ID: 10382022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum concentrations and efficacy of phenytoin, phenobarbital, and primidone in canine epilepsy.
    Farnbach GC
    J Am Vet Med Assoc; 1984 May; 184(9):1117-20. PubMed ID: 6725128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of phenobarbital in dogs after multiple oral administration.
    Ravis WR; Nachreiner RF; Pedersoli WM; Houghton NS
    Am J Vet Res; 1984 Jul; 45(7):1283-6. PubMed ID: 24049884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of phenobarbitone on serum biochemical tests in dogs.
    Foster SF; Church DB; Watson AD
    Aust Vet J; 2000 Jan; 78(1):23-6. PubMed ID: 10736679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy and safety of imepitoin in comparison with phenobarbital for the control of idiopathic epilepsy in dogs.
    Tipold A; Keefe TJ; Löscher W; Rundfeldt C; de Vries F
    J Vet Pharmacol Ther; 2015 Apr; 38(2):160-8. PubMed ID: 25079881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of a therapeutic drug monitoring service as an aid to the control of canine seizures.
    Morton DJ; Honhold N
    Vet Rec; 1988 Apr; 122(15):346-9. PubMed ID: 3381449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on therapy of canine epilepsy.
    Dowling PM
    Can Vet J; 1999 Aug; 40(8):595-8. PubMed ID: 12001345
    [No Abstract]   [Full Text] [Related]  

  • 19. A single-blinded phenobarbital-controlled trial of levetiracetam as mono-therapy in dogs with newly diagnosed epilepsy.
    Fredsø N; Sabers A; Toft N; Møller A; Berendt M
    Vet J; 2016 Feb; 208():44-9. PubMed ID: 26639829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Phenobarbitone Levels in Term and Near Term Neonates with Seizures.
    Wasim S; Upadhyay A; Roy M; Saxena P; Chillar N
    Indian Pediatr; 2016 May; 53(5):388-90. PubMed ID: 27254045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.